Bleichroeder’s Global Blood Therapeutics GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
BBA
Bleichroeder's GBT Position: Q1 2022 in Review
Bleichroeder sold out of Global Blood Therapeutics (GBT) in Q1 2022, closing a stake of 125,000 shares — an estimated $3.66M sold.
Bleichroeder first reported a position in GBT in Q1 2021 and held it in 4 quarters. The position peaked at $4.08M in Q1 2021. 204 funds tracked by Wall St. Rank hold GBT as of Q1 2022.
- Bleichroeder reported no remaining Global Blood Therapeutics position as of Q1 2022 after selling out during the quarter.
- Bleichroeder sold 125,000 Global Blood Therapeutics shares in Q1 2022, an estimated $3.66M.
- Bleichroeder first reported a position in Global Blood Therapeutics in Q1 2021 and held it in 4 quarters.
- Bleichroeder's Global Blood Therapeutics position peaked at $4.08M in Q1 2021.
- 204 funds tracked by Wall St. Rank held Global Blood Therapeutics as of Q1 2022.
Based on Bleichroeder's 13F filing for Q1 2022, filed 11 May 2022.